FMP
Protagenic Therapeutics, Inc.
PTIX
NASDAQ
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.
0.3 USD
0.0412 (13.73%)
PTIX Financial Statements
Year
2024
2023
2022
2021
CF from Operating Activities
-4.22M
-3.7M
-1.99M
-2.8M
Net Income
-5.53M
-5M
-3.56M
-4.52M
Depreciation & Amortization
50.29k
28.22k
30
427.14k
Deferred Income Taxes
0
0
0
-427.14k
Stock Based Compensation
923.14k
666.83k
864.68k
1.52M
Change in Working Capital
467.54k
-114.41k
540.13k
-140.39k
Accounts Receivable
0
0
0
0
Inventory
0
0
0
0
Accounts Payable
0
-27.33k
-91.6k
340.12k
Other Working Capital
467.54k
-87.09k
631.73k
-480.51k
Other Non-Cash Items
-132.14k
716.09k
156.85k
345.95k
CF from Investing Activities
2.8M
4.78M
1.6M
-9.91M
Investments in Property, Plant & Equipment
0
-149.78k
-1.8k
0
Net Acquisitions
0
0
46.05k
0
Investment Purchases
-297.12k
-2.76M
-34.12k
-10.4M
Sales/Maturities of Investments
3.05M
7.69M
1.63M
485.95k
Other Investing Activites
51.73k
0
-46.05k
-9.91k
CF from Financing Activities
1.96M
0
0
12.58M
Debt Repayment
0
0
0
-100k
Common Stock Issued
1.96M
0
0
11.71M
Common Stock Repurchased
0
0
0
0
Dividends Paid
0
0
0
0
Other Financing Activites
1.96M
0
0
869.63k
Free Cash Flow
-4.22M
-3.85M
-2M
-2.8M
Operating Cash Flow
-4.22M
-3.7M
-1.99M
-2.8M
Capital Expenditures
0
-149.78k
-1.8k
0
Cash at Beginning of Period
1.29M
215.19k
541.17k
671.09k
Cash at End of Period
1.84M
1.29M
215.19k
541.17k
Net Change In Cash
550.58k
1.07M
-325.98k
-129.92k
Retained Earning Schedule
Year
2024
2023
2022
2021
Retained Earnings (Previous Year)
-30.78M
-25.78M
-22.22M
-17.7M
Net Income
-5.53M
-5M
-3.6M
-4.99M
Stock Repurchases
0
0
0
0
Dividend Paid
0
0
0
0
Retained Earnings
-36.3M
-30.78M
-25.78M
-22.22M
Other Distributions
-5.53M
-5M
-3.56M
-4.52M
PPE Schedule
Year
2024
2023
2022
2021
Gross PPE
0
123.33k
1.77k
0
Annual Depreciation
0
28.22k
30
286
Capital Expenditure
0
-149.78k
-1.8k
0
Net PPE
0
244.89k
3.55k
-286
Intangible and Goodwill Schedule
Year
2024
2023
2022
2021
Acquisitions and Adjustments
0
0
0
0
Goodwill (Previous Year)
0
0
0
0
Goodwill
0
0
0
0
All figures are in USD.
